HRS 4642 Injection

HRS-4642 · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS 4642 Injection, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer [Phase 3]

See pricing